Trial Profile

A Phase 1b, exploratory clinical study of TG-02 in pediatric patients with diffuse intrinsic pontine glioma (DIPG)

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 05 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zotiraciclib (Primary)
Indications Diffuse intrinsic pontine glioma
Focus Adverse reactions
Sponsors Adastra Pharmaceuticals

Most Recent Events

04 Sep 2019 Status changed from planning to recruiting, as reported in an Pharmaceuticals media release.
07 Jan 2019 New trial record
03 Jan 2019 According to a Adastra Pharmaceuticals media release, the company expects to initiate this study in the second quarter of 2019.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com